Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer

Oncology Reports

Volumn 31, Issue 6, 2014, Pages 2660-2668

  Kong, Fei Fei ^a   Qu, Zeng Qiang ^b   Yuan, Hai Hua ^a   Wang, Jiong Yi ^a   Zhao, Mei ^a   Guo, Yue Hui ^a   Shi, Jing ^a   Gong, Xiao Di ^a   Zhu, You Long ^a   Liu, Feng ^a   Zhang, Wen Ying ^a   Jiang, Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AKT; E cadherin; Epithelial mesenchymal transition; FOXM1; Non small cell lung cancer; Vimentin

Indexed keywords

FORKHEAD BOX M1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN KINASE B; S6 KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; FOXM1 PROTEIN, HUMAN; ONCOPROTEIN;

ADULT; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOKING; SURVIVAL; TISSUE MICROARRAY; WESTERN BLOTTING; AGED; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEIN V-AKT; PROGNOSIS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

EID: 84902145041     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3129     Document Type: Article

References (42)

1. Herbst RS, Heymach JV and Lippman SM: Lung Cancer. N Engl J Med 359: 1367-1380, 2008.
2. Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
3. Laoukili J, Kooistra MR, Brás A, et al: FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7: 126-136, 2005. (Pubitemid 40268127)
4. Laoukili J, Stahl M and Medema RH: FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 1775: 92-102, 2007. (Pubitemid 44881197)
5. Wierstra I and Alves J: FOXM1, a typical proliferation-associated transcription factor. Biol Chem 388: 1257-1274, 2007. (Pubitemid 350135573)
6. Yang DK, Son CH, Lee SK, Choi PJ, Lee KE and Roh MS: Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance. Hum Pathol 40: 464-470, 2009.
7. Sun HC, Li M, Lu JL, et al: Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma. Oncol Rep 25: 1533-1539, 2011.
8. Bektas N, Haaf At, Veeck J, et al: Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer 8: 42, 2008.
9. Liu D, Zhang Z and Kong CZ: High FOXM1 expression was associated with bladder carcinogenesis. Tumour Biol 34: 1131-1138, 2013.
10. Wu XR, Chen YH, Liu DM, Sha JJ, Xuan HQ, Bo JJ and Huang YR: Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma. Med Oncol 30: 346, 2013.
11. He SY, Shen HW, Xu L, et al: FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer. Gynecol Oncol 127: 601-610, 2012.
12. Xu N, Jia D, Chen W, et al: FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis. PLoS One 8: e59412, 2013.
13. Chu XY, Zhu ZM, Chen LB, et al: FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer. Acta Histochem 114: 755-762, 2012.
14. Xue YJ, Xiao RH, Long DZ, et al: Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. J Transl Med 10: 200, 2012.
15. Wang Z, Banerjee S, Kong D, Li Y and Sarkar FH: Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67: 8293-8300, 2007. (Pubitemid 47395167)
16. Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K and Reginato MJ: Critical role of O-linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem 287: 11070-11081, 2012.
17. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
18. Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelialmesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
19. Wu YD and Zhou BP: Snail: more than EMT. Cell Adh Migr 4: 199-203, 2010.
20. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006.
21. Zeisberg M and Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437, 2009.
22. Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM and Goldman RD: Introducing intermediate filaments: from discovery to disease. J Clin Invest 119: 1763-1771, 2009.
23. Cheng GZ, Park S, Shu S, et al: Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 8: 2-6, 2008. (Pubitemid 351237904)
24. Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H and Sato M: Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol 29: 1133-1138, 2006.
25. Grille SJ, Bellacosa A, Upson J, et al: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003. (Pubitemid 36538623)
26. Larue L and Bellacosa A: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 24: 7443-7454, 2005. (Pubitemid 41637984)
27. Schramek H, Feifel E, Marschitz I, Golochtchapova N, Gstraunthaler G and Montesano R: Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells. Am J Physiol Cell Physiol 285: C652-C661, 2003. (Pubitemid 37022064)
28. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006. (Pubitemid 43278296)
29. Park HJ, Gusarova G, Wang Z, et al: Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med 3: 21-34, 2011.
30. Zhao M, Gao FH, Wang JY, Liu F, Yuan HH, Zhang WY and Jiang B: JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer. Lung Cancer 73: 366-374, 2011.
31. Bao B, Wang Z, Ali S, Kong D, et al: Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 112: 2296-2306, 2011.
32. Liu YQ, Guo RH, Liu LK, Gao W, Zhu CJ, Wei J and Shu YQ: Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC). Zhonghua Zhong Liu Za Zhi 33: 426-430, 2011 (In Chinese).
33. Li LP, Lu CH, Chen ZP, et al: Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer. Proteomics 11: 429-439, 2011.
34. Wang G, Dong W, Shen H, Mu X, Li Z, Lin X, Liu Y and Du J: A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases. Eur J Cardiothorac Surg 39: 1028-1032, 2011.
35. Pirozzi G, Tirino V, Camerlingo R, et al: Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS One 6: e21548, 2011.
36. Soltermann A, Tischler V, Arbogast S, et al: Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 14: 7430-7437, 2008.
37. Zhao JQ, Sun FJ, Liu SS, et al: Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients. Asian Pac J Cancer Prev 14: 639-643, 2013.
38. Zhang X, Wang Z, Kang Y, Li X, Ma X and Ma L: MCAM expression is associated with poor prognosis in non-small cell lung cancer. Clin Transl Oncol 16: 178-183, 2014.
39. Jin S, Zhu W, Shi Q, Zhang Z and Guo R: Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer. Med Oncol 29: 3157-3161, 2012.
40. Ucvet A, Kul C, Gursoy S, Erbaycu AE, Kaya SO, Dinc ZA and Yucel N: Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma. Arch Bronconeumol 47: 397-402, 2011 (In Spanish).
41. Dauphin M, Barbe C, Lemaire S, et al: Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas. Lung Cancer 81: 117-122, 2013.
42. Irie HY, Pearline RV, Grueneberg D, et al: Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171: 1023-1034, 2005. (Pubitemid 41815834)